Literature DB >> 19463535

Acute management of Stevens-Johnson syndrome and toxic epidermal necrolysis to minimize ocular sequelae.

Scheffer C G Tseng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19463535      PMCID： PMC3182483          DOI： 10.1016/j.ajo.2009.02.011

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  17 in total

1.  Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction.

Authors:  M Ueta; M-N Kweon; Y Sano; C Sotozono; J Yamada; N Koizumi; H Kiyono; S Kinoshita
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

3.  Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.

Authors:  A Heiligenhaus; D Bauer; D Meller; K P Steuhl; S C Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

4.  Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK.

Authors:  W C Park; S C Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

5.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Authors:  Ariane Auquier-Dunant; Maja Mockenhaupt; Luigi Naldi; Osvaldo Correia; Werner Schröder; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2002-08

Review 6.  Differential diagnosis of severe cutaneous drug eruptions.

Authors:  Nicolas Bachot; Jean-Claude Roujeau
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

7.  Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.

Authors:  Yayoi Araki; Chie Sotozono; Tsutomu Inatomi; Mayumi Ueta; Norihiko Yokoi; Eiichiro Ueda; Saburo Kishimoto; Shigeru Kinoshita
Journal:  Am J Ophthalmol       Date:  2009-03-14       Impact factor: 5.258

Review 8.  Delayed drug hypersensitivity reactions.

Authors:  Werner J Pichler
Journal:  Ann Intern Med       Date:  2003-10-21       Impact factor: 25.391

9.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Authors:  S Bastuji-Garin; B Rzany; R S Stern; N H Shear; L Naldi; J C Roujeau
Journal:  Arch Dermatol       Date:  1993-01

10.  Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.

Authors:  H Assier; S Bastuji-Garin; J Revuz; J C Roujeau
Journal:  Arch Dermatol       Date:  1995-05
View more
  4 in total

1.  Toxic epidermal necrolysis - management issues and treatment options.

Authors:  Alan D Widgerow
Journal:  Int J Burns Trauma       Date:  2011-09-03

Review 2.  Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions.

Authors:  Robert A Case; Vishal Patel; Carolina Mejia-Otero; Alan E Siroy; Divya C Patel
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

Review 3.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

4.  Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome.

Authors:  Han Y Yin; Nicholas Hadjokas; Kanish Mirchia; Robert Swan; Samuel Alpert
Journal:  Case Rep Ophthalmol Med       Date:  2020-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.